Boston Scientific CEO named to CVS board
Photo | Courtesy of Boston Scientific
Michael Mahoney, chairman and CEO of Boston Scientific
CVS Health, headquartered in Woonsocket, Rhode Island, has named Boston Scientific Chairman and CEO Michael Mahoney to its board of directors, effective November 1.
"Mike's focus throughout his career – to drive improvements in health outcomes and increase access to care – align with our mission at CVS Health," CVS Health President and CEO Karen Lynch said in a Thursday press release. "Adding a well-respected health care leader to our Board demonstrates our continued focus on strengthening our engagement with consumers to improve their health and well-being."
Mahoney has been at the helm of Boston Scientific, the Marlborough-based medical device giant, since 2012 and has been the chairman of Boston Scientific’s board since 2016. The publicly traded company reported revenues of nearly $12.7 billion in 2022.
"CVS Health and Boston Scientific share many common goals, with a primary focus on making a real difference for the people and patients we serve," Mahoney said in the press release. "I hope that my experience within the healthcare industry will help me work with the board and the management team to support and advance CVS Health's strategy."
CVS was founded in 1963 in Lowell. It was acquired in 1969 by New York-based holding company Melville. In 1996, CVS split from Melville. In 2018 it acquired Connecticut-based insurer Aetna in a $68-billion transaction.
WBJ Web Partners
Most Recent
Most Recent
0 Comments